After he was diagnosed with a rare form of cancer in 2007, Paul Poth (pictured here with his wife Kristen) founded TargetCancer, Inc., an organization devoted to treating and curing rare forms of cancer. Before he died at age 39, Paul took TargetCancer from its infancy to an organization with deep connections to physicians and researchers studying overlooked forms of the disease. His wife, Kristen Palma Poth, took up the battle on his behalf following Paul’s death, and the organization now raises money and makes grants directly to physician-researchers seeking innovative treatments for some of the rarest and deadliest forms of cancer. One of TargetCancer’s recent grants funded the creation of the first Cholangiocarcinoma (bile duct cancer) Cell Line Bank at Mass General, which is essential to finding treatments for this rare cancer. During his life, Paul had dreamed of creating hope for people diagnosed with rare cancers. The Cell Line Bank is just the beginning of realizing this dream.

Mass General honors 100 individuals and groups for their diverse contributions to the fight against cancer.

There is strength in numbers and Massachusetts General Hospital Cancer Center proves this each year. the one hundred is the Cancer Center’s annual fundraiser, honoring 100 individuals and groups whose diligence and discoveries, philanthropy and passion have helped advance the fight against cancer. Funds raised at the gala support research, patient care, education and community outreach programs.  Meet the Honorees.